Kyverna Therapeutics, Inc.KYTXNASDAQ
Loading
Enterprise value to EBITDA ratio
Latest
-0.44
↑ 100% vs avg
Percentile
P100
Near historical high
Streak
1 yr
Consecutive growthExpanding
Average
-99.95
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2024 | -0.44 | +99.9% |
| 2023 | -345.18 | -1183.6% |
| 2022 | -26.89 | +1.5% |
| 2021 | -27.31 | - |